Will the real Cowden syndrome please stand up: revised diagnostic criteria - PubMed (original) (raw)
Will the real Cowden syndrome please stand up: revised diagnostic criteria
C Eng. J Med Genet. 2000 Nov.
No abstract available
Similar articles
- Will the real Cowden syndrome please stand up (again)? Expanding mutational and clinical spectra of the PTEN hamartoma tumour syndrome.
Pilarski R, Eng C. Pilarski R, et al. J Med Genet. 2004 May;41(5):323-6. doi: 10.1136/jmg.2004.018036. J Med Genet. 2004. PMID: 15121767 Free PMC article. Review. No abstract available. - PTEN hamartoma tumour syndrome: variability of an entity.
Merks JH, de Vries LS, Zhou XP, Nikkels P, Barth PG, Eng C, Hennekam RC. Merks JH, et al. J Med Genet. 2003 Oct;40(10):e111. doi: 10.1136/jmg.40.10.e111. J Med Genet. 2003. PMID: 14569134 Free PMC article. No abstract available. - A novel germline mutation of the PTEN/MMAC1 gene in a patient with Cowden disease.
Sanson M, Zhou XP, Brault JL, Hoang-Xuan K, Hamelin R. Sanson M, et al. Acta Oncol. 1999;38(7):973-5. doi: 10.1080/028418699432699. Acta Oncol. 1999. PMID: 10606430 No abstract available. - Absence of germline mutations in MINPP1, a phosphatase encoding gene centromeric of PTEN, in patients with Cowden and Bannayan-Riley-Ruvalcaba syndrome without germline PTEN mutations.
Dahia PM, Gimm O, Chi H, Marsh DJ, Reynolds PR, Eng C. Dahia PM, et al. J Med Genet. 2000 Sep;37(9):715-7. doi: 10.1136/jmg.37.9.715. J Med Genet. 2000. PMID: 11182934 Free PMC article. No abstract available. - [Cowden disease and the PTEN gene: a successfully clinical and biological combined approach].
Longy M. Longy M. Bull Cancer. 2001 Dec;88(12):1153-8. Bull Cancer. 2001. PMID: 11792608 Review. French.
Cited by
- Exome sequencing in BRCA1-2 candidate familias: the contribution of other cancer susceptibility genes.
Doddato G, Valentino F, Giliberti A, Papa FT, Tita R, Bruno LP, Resciniti S, Fallerini C, Benetti E, Palmieri M, Mencarelli MA, Fabbiani A, Bruttini M, Orrico A, Baldassarri M, Fava F, Lopergolo D, Lo Rizzo C, Lamacchia V, Mannucci S, Pinto AM, Curr A, Mancini V; Oncologic Multidisciplinary Team, Azienda Ospedaliera Universitaria Senese; Oncologic Multidisciplinary Team, Azienda Usl Toscana Sud Est; Mari F, Renieri A, Ariani F. Doddato G, et al. Front Oncol. 2021 May 7;11:649435. doi: 10.3389/fonc.2021.649435. eCollection 2021. Front Oncol. 2021. PMID: 34026625 Free PMC article. - Prevalence of germline PTEN, BMPR1A, SMAD4, STK11, and ENG mutations in patients with moderate-load colorectal polyps.
Ngeow J, Heald B, Rybicki LA, Orloff MS, Chen JL, Liu X, Yerian L, Willis J, Lehtonen HJ, Lehtonen R, Mester JL, Moline J, Burke CA, Church J, Aaltonen LA, Eng C. Ngeow J, et al. Gastroenterology. 2013 Jun;144(7):1402-9, 1409.e1-5. doi: 10.1053/j.gastro.2013.02.001. Epub 2013 Feb 8. Gastroenterology. 2013. PMID: 23399955 Free PMC article. - Molecular pathogenesis of endometrial and ovarian cancer.
Merritt MA, Cramer DW. Merritt MA, et al. Cancer Biomark. 2010;9(1-6):287-305. doi: 10.3233/CBM-2011-0167. Cancer Biomark. 2010. PMID: 22112481 Free PMC article. Review. - Lifetime cancer risks in individuals with germline PTEN mutations.
Tan MH, Mester JL, Ngeow J, Rybicki LA, Orloff MS, Eng C. Tan MH, et al. Clin Cancer Res. 2012 Jan 15;18(2):400-7. doi: 10.1158/1078-0432.CCR-11-2283. Clin Cancer Res. 2012. PMID: 22252256 Free PMC article. - Cowden syndrome: new clinical features in a large family; joint hyperextensibility, dental abnormalities and gingival enlargement.
Sabir A, Parry G, Heaton T, Ong KR. Sabir A, et al. BMJ Case Rep. 2021 Mar 10;14(3):e236768. doi: 10.1136/bcr-2020-236768. BMJ Case Rep. 2021. PMID: 33692038 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials